AGP Executive Report
Last update: 11 hours agoHemp & CBD Product Policy: Pennsylvania’s Senate rejected a bill that would have regulated “intoxicating hemp” and shifted medical marijuana oversight to a cannabis control board, leaving “gas station weed” largely unregulated. Medical Cannabis Expansion: Georgia’s Senate Bill 220 expands medical cannabis options from July 1, adding flower and vape products for faster relief for chronic pain patients. Regulators & Oversight: Rhode Island confirmed Michelle Reddish as the new Cannabis Control Commission chair, keeping the agency focused on regulating medical, recreational, and hemp markets. Animal Health CBD: Trait Biosciences reported early in-home, owner-reported mobility improvements in companion animals after topical CBD82S use, aiming to solve CBD’s water-solubility limits. Youth Use Risk: A Quebec study in Addiction found teen cannabis initiation risk rises most when friends use cannabis and teens believe it’s easy to get. Industry Dealmaking: K&L Gates advised Cannatrek on its approved sale to Little Green Pharma, signaling continued consolidation in Australia’s medicinal cannabis sector. Responsible Use Campaign: St. Kitts and Nevis launched a Responsible Use Campaign emphasizing legal access, medical oversight, and protection of vulnerable populations. Hemp Beverage Push: Hometown Hero will exhibit hemp-derived THC beverages at the Hemp Beverage Expo in Austin.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.